Kerry Wentworth, VP, Clinical, Reg, & Quality at AGENUS INC (AGEN), sold 6,016 shares at $2.24 ($13K) on 2011-12-21, disclosed to the SEC on 2011-12-23.
Open-market sale of $13k AGEN by VP, Clinical, Reg, & Quality. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.24 | 3,414 | $8K | 57.3% |
| 2 | $2.19 | 1,716 | $4K | 28.1% |
| 3 | $2.20 | 886 | $2K | 14.6% |
| Total | $2.22 avg | 6,016 | $13K | 100% |
| Filing → |
| NUVB | SELL | 2026-04-08 | $904K | — | Filing → |
| NUVB | BUY | 2025-06-18 | $90K | — | Filing → |
| FLXN | SELL | 2021-07-20 | $25K | — | Filing → |